Insulin-like growth factor II induces DNA synthesis in fetal ventricular myocytes in vitro

Circulation Research

Volumn 79, Issue 4, 1996, Pages 716-726

  Liu, Qingquan ^a   Yan, Huajun ^a   Dawes, Nicola J ^a   Mottino, Giuliano A ^a   Frank, Joy S ^a   Zhu, Hong ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antisense oligonucleotide; hypertrophy; insulin like growth factor II; proliferation; ventricular myocyte

Indexed keywords

SOMATOMEDIN B;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DNA SYNTHESIS; EMBRYO GROWTH; ENZYME ACTIVITY; HEART MUSCLE CELL; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

EID: 0029838644     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.4.716     Document Type: Article

References (56)

1. Cohich WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol. 1993;55:131-153.
2. Thorburn A, Thorbum J, Chen SY, Powers S, Shubeita HE, Feramisco JR, Chien KR. HRas-dependent pathway can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem. 1993;268:2244-2249.
3. Pfeifer K, Tilghman SM. Allele-specific gene expression in mammals: the curious case of the imprinted RNAs. Genes Dev. 1994;8:1867-1874.
4. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature. 1993;362:747-749.
5. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw WA, Smith PJ, Reeve AE. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumor. Nature. 1993;362:749-751.
6. Zhan S, Shapiro DN, Helman LJ. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest. 1994;94:445-448.
7. van Gurp RJ, Oosterhuis JW, Kalscheuer V, Mariman EC, Looijenga LH. Biallelic expression of the HI 9 and IGF2 genes in human testicular germ cell tumor. J Natl Cancer Inst. 1994;86:1070-1075.
8. Hedborg F, Holmgren L, Sandstedt B, Ohlsson R. The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am J Pathol. 1994;145:802-817.
9. Rainier S, Dobry CJ, Feinberg AP. Loss of imprinting in hepatoblastoma. Cancer Res. 1995;55:1836-1838.
10. Roth RA. Structure of the receptor for insulin-like growth factor II: the puzzle amplified. Science. 1988;239:1269-1271.
11. Sakano K, Enjoh T, Numata F, Fugiwara H, Marumoto Y, Higashihashi N, Sato Y, Perdue JF, Fujita-Yamaguchi Y. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose-6-phosphate receptor or IGF-I receptor. J Biol Chem. 1991;266:20626-20635.
12. Rappelee DA, Sturm KS, Behrendtsen O, Schultz GA, Pedersen RA, Werb Z. Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev. 1992;6:939-952.
13. Bondy CA, Werner H, Roberts CT Jr, LeRoith D. Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol. 1990;4:1386-1398.
14. Adamo M, Lowe WL Jr, LeRoith D, Roberts CT Jr. Insulin-like growth factor I messenger ribonucleic acids with alternative 5′-untranslated regions are differentially expressed during development of the rat. Endocrinology. 1989;124:2737-2744.
15. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990;345:78-80.
16. MacDonald RG, Pfeffer SR, Coussens MA, Brocklebank CM, Mole JE, Anderson JK, Chen E, Czech MP, Ullrich A. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science. 1988;239:1134-1137.
17. Czech MP. Signal transmission by the insulin-like growth factor. Cell. 1989;59:235-238.
18. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 1994;8:2953-2963.
19. Filson AJ, Louvi A, Efstratiadis A, Robertson EJ. Rescue of the T-associated maternal effect in mice carrying null mutations in IGF-2 and Igf2r, two reciprocally imprinted genes. Development. 1993;118:731-736.
20. Zhu H, Nguyen VTB, Brown AB, Pourhosseini A, Garcia AV, van Bilsen M, Chien KR. A novel, tissue-restricted zinc finger protein (HF-1b) binds to the cardiac regulatory element (HF-1b/MEF-2) in the rat myosin light-chain 2 gene. Mol Cell Biol. 1993;13:4432-4444.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. Iwaki K, Sukhame VP, Shubeita HE, Chien KR. α- and β-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J Biol Chem. 1990;265:13809-13817.
23. Wagner RW, Mateucci MD, Lewis JG, Gutierrez AJ, Moulds C, Froehler BS. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science. 1993;260:1510-1513.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
25. Kull FC, Jacobs S, Su Y-F, Svoboda ME, Van Wyk JJ, Cuatrecasas P. Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem. 1983;258:6561-6566.
26. Rohlik QT, Adams D, Kull FC, Jacobs S. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun. 1987;149:276-281.
27. Claycomb WC. Cardiac muscle cell proliferation and cell differentiation in vivo and in vitro. Adv Exp Med Biol. 1983;161:249-265.
28. Soares MB, Turken A, Ishii D, Mills L, Episcopou V, Cotter S, Zeitlin S, Efstratiadis A. Rat insulin-like growth factor II gene: a single gene with two promoters expressing a multitranscript family. J Mol Biol. 1986;192:737-752.
29. Frunzio R, Chiariotti L, Brown AL, Graham DE, Rechler MM, Bruni CD. Structure and expression of the insulin-like growth factor II (rIGF-II) gene. J Biol Chem. 1986;261:17138-17149.
30. Ueno T, Takahashi K, Matsuguchi T, Endo H, Yamamoto M. A new leader exon identified in the rat insulin-like growth factor II gene. Biochem Biophys Res Commun. 1987;148:344-349.
31. Evans T, DeChiara A, Efstratiadis A. A promoter of the rat insulin-like growth factor II gene consists of minimal control elements. J Mol Biol 1988;199:61-81.
32. Ueno T, Takahashi K, Matruguchi T, Endo H, Yamamoto M. Transcriptional deviation of the rat insulin-like growth factor II gene initiated at three alternative leader-exons between neonatal tissues and ascites hepatomas. Biochim Biophys Acta. 1988;950:411-419.
33. Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994;79:551-555.
34. Stiles CD, Capone GT, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci U S A. 1979;76:1279-1283.
35. Campisi J, Pardee AB. Post-transcriptional control of the onset of DNA synthesis by an insulin-like growth factor. Mol Cell Biol. 1984;4:1807-1814.
36. Florini IR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS. 'Spontaneous' differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem. 1991;266:15917-15923.
37. Guler HP, Zapf J, Schnid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Acta Endocrinol (Copenh). 1989;121:753-758.
38. Speir E, Tanner V, Gonzalez AM, Farris J, Baird A, Casscells W. Acidic and basic fibroblast growth factors in adult rat heart myocytes: localization, regulation in culture, and effects on DNA synthesis. Circ Res. 1992;71:251-259.
39. Pasumarthi KBS, Kardami E, Cattini PA. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology: evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ Res. 1996;78:126-136.
40. Pasumarthi KBS, Doble BW, Kardami E, Cattini PA. Over-expression of CUG or AUG-initiated forms of basic fibroblast growth factor in cardiac myocytes results in similar effects on mitosis and protein synthesis but distinct nuclear morphologies. J Mol Cell Cardiol. 1994;26:1045-1060.
41. Oberpriller JO, Oberpriller JC. Cell division in adult newt cardiac myocytes. In: The Developmental and Regenerative Potential of Cardiac Muscle. New York, NY: Harwood; 1991:293-311.
42. Soonpaa MH, Oberpriller JO, Oberpriller JC. Factors altering DNA synthesis in the cardiac myocyte of the adult newt, Notophthalmus viridescens. Cell Tissue Res. 1994;275:377-382.
43. Soonpaa MH, Oberpriller JO, Oberpriller JC. Stimulation of DNA synthesis by PDGF in the newt cardiac myocytes. J Mol Cell Cardiol. 1992;24:1039-1046.
44. 1. Mol Cell Biochem. 1994;141:145-151.
45. Palmer JN, Hartogenesis WE, Patten M, Fortuin FD, Long CS. Interleukin-1β induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest. 1995;95:2555-2564.
46. Kirshenbaum LA, Schneider MD. Adenovirus E1 A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domain. J Biol Chem. 1995;270:7791-7794.
47. Liu Y, Kitsis RN. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J Cell Biol. 1996;133:325-334.
48. Crescenzi M, Fleming TP, Lassar AB, Weintraub H, Aaronson SA. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc Natl Acad Sci U S A. 1990;87:8842-8846.
49. Sorrentino R, Pepperkok R, Davis RL, Anorge W, Philipson L. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature. 1990;345:813-815.
50. Kajstura J, Cheng W, Reiss K, Anversa P. The IGF-1-IGF-1 receptor system modulates myocyte proliferation but not myocyte cellular hypertrophy in vitro. Exp Cell Res. 1994;215:273-283.
51. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M, Koike A, Nogami A, Marumo F. Insulinlike growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 1993;87:1715-1721.
52. Shier P, Watt VM. Primary structure of a putative receptor for a ligand of the insulin family. J Biol Chem. 1989;264:14605-14608.
53. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75:73-82.
54. 1-adrenergic stimulation. J Biol Chem. 1994;269:13490-13496.
55. Lu K, Campisi J. Ras proteins are essential and selective for the action of insulin-like growth factor 1 late in the G1 phase of the cell cycle in BALB/c murine fibre-blasts. Proc Natl Acad Sci U S A. 1992;89:3889-3893.
56. Hu ZW, Shi XY, Hoffman BB. Insulin and insulin-like growth factor I induce α1D-adrenergic receptor expression in cultured vascular smooth muscle cell. Circulation. 1995;92(suppl I):I-370. Abstract.